Crooks, B N <br/><br/>
Adverse neonatal effects of maternal labetalol treatment.  [electronic resource] 

 -  Archives of disease in childhood. Fetal and neonatal edition  Sep 1998 
 - F150-1 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1359-2998 
<br/><br/><label>Standard No.: </label>10.1136/fn.79.2.f150  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic beta-Agonists--therapeutic use<br/>Adrenergic beta-Antagonists--adverse effects<br/>Adult<br/>Cardiomegaly--chemically induced<br/>Dobutamine--therapeutic use<br/>Dopamine--therapeutic use<br/>Drug Therapy, Combination<br/>Fatal Outcome<br/>Female<br/>Glucagon--therapeutic use<br/>Humans<br/>Infant, Newborn<br/>Labetalol--adverse effects<br/>Norepinephrine--therapeutic use<br/>Pericardial Effusion--chemically induced<br/>Pregnancy<br/>Pregnancy Complications, Cardiovascular--drug therapy<br/>Prenatal Exposure Delayed Effects